{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:27:49Z","timestamp":1789846069668,"version":"4.0.1"},"reference-count":17,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The persistence of anti-\n            <jats:italic>Leishmania donovani<\/jats:italic>\n            antibodies in past visceral leishmaniasis (VL) cases was retrospectively assessed by means of the direct agglutination test (DAT) and the rK39 enzyme-linked immunosorbent assay (ELISA). Antibody titers remained high for an extended period of time in past cases of VL. These results highlight the need to carefully elicit the history of patients with VL symptoms.\n          <\/jats:p>","DOI":"10.1128\/cvi.00473-10","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T03:51:11Z","timestamp":1292471471000},"page":"346-348","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":61,"title":["Persistence of\n            <i>Leishmania donovani<\/i>\n            Antibodies in Past Visceral Leishmaniasis Cases in India"],"prefix":"10.1128","volume":"18","author":[{"given":"Kamlesh","family":"Gidwani","sequence":"first","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Picado","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Ostyn","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shri Prakash","family":"Singh","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basudha","family":"Khanal","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Lejon","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327ois","family":"Chappuis","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[{"name":"Banaras Hindu University, Varanasi, India"},{"name":"Institute of Tropical Medicine, Antwerp, Belgium"},{"name":"B. P. Koirala Institute of Health Sciences, Dharan, Nepal"},{"name":"Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"195","volume":"123","year":"2006","unstructured":"Bhattacharya, S. K., D. Sur, P. K. Sinha, and J. Karbwang. 2006. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Indian J. Med. Res. 123:195-196.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-3156.2009.02242.x","volume":"14","year":"2009","unstructured":"Bhattarai, N. R., et al. 2009. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop. Med. Int. Health 14:404-411.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trstmh.2007.09.003","volume":"102","year":"2008","unstructured":"Boelaert, M., et al. 2008. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans. R. Soc. Trop. Med. Hyg. 102:32-40.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.2006.75.739","volume":"75","year":"2006","unstructured":"De Almeida Silva, L., et al. 2006. Immunologic tests in patients after clinical cure of visceral leishmaniasis. Am. J. Trop. Med. Hyg. 75:739-743.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.7.1321-1325.1988"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0035-9203(90)90141-Z","volume":"84","year":"1990","unstructured":"Hailu, A. 1990. Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:673-675.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1365-3156.2006.01743.x","volume":"11","year":"2006","unstructured":"Jacquet, D., et al. 2006. Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT\/VL). Trop. Med. Int. Health 11:1777-1784.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_9_2","unstructured":"Trop. Med. Int. Health"},{"key":"e_1_3_2_10_2","first-page":"1410","volume":"12","year":"2005","unstructured":"Kurkjian, K. M., et al. 2005. Application of an improved method for the recombinant K39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Clin. Diagn. Lab. Immunol. 12:1410-1415.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_11_2","unstructured":"Template for developing district action plan (kala-azar)"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","volume":"13","year":"1995","unstructured":"Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.","journal-title":"Annu. Rev. Immunol."},{"key":"e_1_3_2_13_2","first-page":"412","volume":"47","year":"2009","unstructured":"Sharma, U., and S. Singh. 2009. Immunobiology of leishmaniasis. Indian J. Exp. Biol. 47:412-423.","journal-title":"Indian J. Exp. Biol."},{"key":"e_1_3_2_14_2","first-page":"568","volume":"9","year":"2002","unstructured":"Singh, S., V. Kumari, and N. Singh. 2002. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin. Diagn. Lab. Immunol. 9:568-572.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-3156.2010.02519.x","volume":"15","year":"2010","unstructured":"Singh, S. P., et al. 2010. The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop. Med. Int. Health 15(Suppl. 2):12-20.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-3156.2006.01647.x","volume":"11","year":"2006","unstructured":"Singh, S. P., D. C. Reddy, M. Rai, and S. Sundar. 2006. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop. Med. Int. Health 11:899-905.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_17_2","first-page":"38","volume":"128","year":"2008","unstructured":"Thakur, C. P., et al. 2008. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J. Med. Res. 128:38-44.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.5.717-720.1998"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00473-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00473-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:45:02Z","timestamp":1627591502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00473-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1128\/CVI.00473-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00473-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"2010-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}